| Literature DB >> 31431817 |
Makoto Takeuchi, Kazunori Nagasaka1, Mina Yoshida2, Yoshiko Kawata3, Yuko Miyagawa1, Saori Tago2, Haruko Hiraike1, Osamu Wada-Hiraike1, Katsutoshi Oda3, Yutaka Osuga3, Tomoyuki Fujii3, Takuya Ayabe1, Soo Hyeon Kim, Teruo Fujii2.
Abstract
Several specific tests for cervical screening have been developed recently, including p16/Ki67 dual immunostaining for diagnosing high-risk human papillomavirus positive squamous intraepithelial lesion in the cervix. However, manual screening of cells in an entire glass slide is currently a standard clinical procedure for quantification and interpretation of immunocytochemical features of the cells. Here, we developed a microfluidic device containing an electroactive microwell array with barriers (EMAB) for highly efficient single-cell trapping followed by on-chip immunofluorescence analysis with minimum loss of the sample. EMAB utilizes patterned electrodes at the bottom of cell-sized microwells to trap single cells using dielectrophoresis (DEP) and cell-holding structures behind the microwells to stabilize the position of trapped cells even without DEP. Using the device, we evaluated the performance of p16/Ki67 dual immunostaining of HeLa cells on the chip. The device shows 98% cell-trapping efficiency as well as 92% cell-holding efficiency against the fixed HeLa cells, and we successfully demonstrated high-efficiency on-chip immunofluorescence analysis with minimal loss of sample. p16/Ki67 dual immunostaining using EMAB may be useful for complementary tests for cervical screening in confirming the histopathological diagnosis.Entities:
Year: 2019 PMID: 31431817 PMCID: PMC6697034 DOI: 10.1063/1.5089796
Source DB: PubMed Journal: Biomicrofluidics ISSN: 1932-1058 Impact factor: 2.800